The objective was to assess the presence and extent of venous thromboembolic (VTE) surveillance bias using high-quality clinical data. Background: Hospital VTE rates are publicly reported and used in pay-forperformance programs. Prior work suggested surveillance bias: hospitals that look more for VTE with imaging studies find more VTE, thereby incorrectly seem to have worse performance. However, these results have been questioned as the risk adjustment and VTE measurement relied on administrative data. Methods: Data (2009Data ( -2010 from 208 hospitals were available for analysis. Hospitals were divided into quartiles according to VTE imaging use rates (Medicare claims). Observed and risk-adjusted postoperative VTE event rates (regression models using American College of Surgeons National Surgical Quality Improvement Project data) were examined across VTE imaging use rate quartiles. Multivariable linear regression models were developed to assess the impact of hospital characteristics (American Hospital Association) and hospital imaging use rates on VTE event rates. Results: The mean risk-adjusted VTE event rates at 30 days after surgery increased across VTE imaging use rate quartiles: 1.13% in the lowest quartile to 1.92% in the highest quartile (P < 0.001). This statistically significant trend remained when examining only the inpatient period. Hospital VTE imaging use rate was the dominant driver of hospital VTE event rates (P < 0.001), as no other hospital characteristics had significant associations. Conclusions: Even when examined with clinically ascertained outcomes and detailed risk adjustment, VTE rates reflect hospital imaging use and perhaps signify vigilant, high-quality care. The VTE outcome measure may not be an accurate quality indicator and should likely not be used in public reporting or pay-for-performance programs.
V enous thromboembolism (VTE), which comprises deep vein thrombosis (DVT) and pulmonary embolism (PE), is a potentially life-threatening complication among hospitalized patients, particularly after major surgery. [1] [2] [3] [4] mately 1% of all patients undergoing surgery in the United States. 2, 5 Quality-of-care measures for VTE are included in many hospital quality improvement and public reporting initiatives in an effort to lower postoperative VTE rates. 6, 7 VTE is a "never event" that is not additionally reimbursed by the Centers for Medicare & Medicaid Services after certain operations. 8, 9 VTE performance will also be tied to financial penalties through the 2015 Centers for Medicare & Medicaid Services Hospital Value-based Purchasing program.
However, the validity of the VTE measure has been questioned. 10, 11 Several studies have suggested a so-called surveillance bias or "the more you look, the more you find" phenomenon. [11] [12] [13] [14] [15] Hospitals that are vigilant, look more frequently for VTE, and find more VTE are then inadvertently penalized for having high VTE rates. However, the only comprehensive study examining this issue used Medicare administrative claims data limited to patients 65 years and older. 10 Compared with data from clinical registries, administrative data are not as accurate for ascertaining true VTE events, as administrative data have been shown to have high false-positive and false-negative rates. [16] [17] [18] Moreover, administrative data are limited in the preoperative risk factors and comorbidities available for detailed risk adjustment. The administrative data are generally also limited to the inpatient-only period, but the postdischarge period is important given the relatively high proportion of events that occur outside the hospitals, especially with increasingly shorter lengths of stay. 19 To address these limitations of our prior study of surveillance bias and VTE, we used high-quality clinical data including a wide range of age groups and operative procedures from the American College of Surgeons National Surgical Quality Improvement Project (ACS NSQIP). 20 ACS NSQIP data have been shown to be more accurate than administrative data, given its rigorous data collection system using standardized definitions and thorough validation process through formal audits. 17 ACS NSQIP data also capture both inpatient and postdischarge events to 30 days after index surgery and contain more than 30 variables for comprehensive risk adjustment. Therefore, the objectives of this study were (1) to examine whether a surveillance bias is associated with measured VTE event rates using robust clinical data and (2) to assess whether VTE imaging use rates or other hospital characteristics are associated with VTE event rates. We hypothesized that hospitals with higher VTE imaging use rates would have higher VTE events rates when using accurate, standardized, audited, and validated clinical data from ACS NSQIP. By using Medicare data to assess hospital VTE imaging use and ACS NSQIP data to ascertain VTE events and perform risk adjustment, this study offers the only way available currently to examine this issue using clinical data from a large sample of hospitals. audit process. 21 Outcomes are ascertained by the data abstractors in a standardized fashion at 30 days after the index surgery irrespective of whether the patient is inpatient, discharged, or admitted at another institution.
Patients 18 years or older who underwent 11 major surgical procedures (abdominal aortic aneurysm repair, bariatric surgery, brain tumor resection, colon resection, coronary artery bypass graft, cystectomy, esophagectomy, lung resection, pancreatectomy, rectal surgery, and total knee arthroplasty) were identified using the American Medical Association Current Procedural Terminology codes (see Supplemental Digital Content Table 1 , available at http://links.lww.com/SLA/A596). The procedures were selected as they have policy relevance or are frequently examined in surgical quality evaluations.
When coded by the data abstractors, the ACS NSQIP definition of DVT and PE requires image confirmation and treatment of the blood clot. Hospital risk-adjusted VTE event rates were calculated using the standard ACS NSQIP modeling approach that has been previously well described and accounts for differences in patient comorbidities. 22 More than 30 patient characteristics were available for risk adjustment in multivariable logistic regression models including age, sex, race, American Society of Anesthesiologists physical status classification, functional status, comorbidities, and abnormal preoperative laboratory values. Risk-adjusted VTE, DVT, and PE rates were calculated for events occurring within 30 days after the index operation and also for events that occurred only during the index inpatient postoperative stay.
Hospital VTE Imaging Use Rates
Data on hospital VTE imaging studies were obtained from the Medicare Provider and Analysis Review, Carrier, and Outpatient claims files from January 1, 2009, to December 31, 2010. This currently represents the only way to obtain detailed data on VTE imaging use rates for most hospitals in the United States. Using International Classification of Diseases, Ninth Revision (ICD-9), codes (see Supplemental Digital Content Table 1 , available at http: //links.lww.com/SLA/A596), patients older than 65 years who underwent the same 11 major surgical procedures noted earlier were identified.
VTE imaging studies (venous duplex ultrasonogram of upper or lower extremity for DVT; chest computed tomographic scans, chest magnetic resonance image, ventilation-perfusion scans, and venograms for PE) were identified using the Centers for Medicare & Medicaid Services Healthcare Common Procedure Coding System) codes (see Supplemental Digital Content Table 3 , available at http://links.lww.com/SLA/A596) for postoperative services rendered during the inpatient period. Hospital VTE imaging use rates were defined as the number of surgical (Medicare) discharges that had any VTE-related imaging studies obtained per the total number of Medicare surgical discharges. VTE, DVT, and PE were examined separately. The hospitals were then divided into 4 quartiles using VTE imaging use rates, with approximately equal numbers of hospitals in each quartile.
Hospital Characteristics
Hospital structural characteristics were identified from the 2010 American Hospital Association Annual Survey. [23] [24] [25] [26] [27] [28] [29] These characteristics reflect a hospital's resources and focus on specialized programs designed and intended to provide higher quality care. 30 Bed size was dichotomized to fewer than 500 and 500 or more beds. Teaching status was determined by whether the hospital was a member of Council of Teaching Hospitals and Health Systems of the Association of American Medical Colleges or had other teaching hospital designation (ie, residency training approval from the Accreditation Council for Graduate Medical Education, medical school affiliation with the American Medical Association or the American Osteopathic Association). 31 Structural quality characteristics included Joint Commission accreditation; presence of a cancer program approved by the ACS Commission on Cancer; certification as a level I trauma center; provision of burn care services; and provision of transplant surgery services. In addition, the number of individual structural quality characteristics for each hospital were summed (5 total) to evaluate how an increasing number of characteristics would affect performance on risk-adjusted VTE, DVT, and PE event rates.
Statistical Analysis
Data regarding hospital VTE imaging use rates, VTE event rates, and structural characteristics were merged for each hospital. Only hospitals with data for both VTE imaging use rates and VTE event rates were included in the analysis. Hospitals were grouped into quartiles on the basis of VTE imaging use rates.
The relationship between hospital DVT and PE imaging rates was assessed with bivariate Spearman correlations. Hospitalobserved and risk-adjusted VTE event rates during the inpatient-only and at 30-day postoperative periods were examined by the quartile of VTE imaging use rate. The Cuzick extension of the Wilcoxon rank-sum test was used to test for significant trends across quartiles. One-way analysis of variance with Bonferroni corrections for multiple pairwise comparisons was used to test for differences in mean rates of VTE events across VTE imaging use rate quartiles. Sensitivity analyses were performed for DVT-and PE-only events and imaging use.
The association between hospital risk-adjusted VTE, DVT, and PE event rates and hospital characteristics (bed size, teaching status, number of structure quality characteristics, and hospital VTE imaging use rate) was examined using multivariable linear regression. VTE, DVT, and PE were examined separately.
Because the imaging data came from Medicare claims, and Medicare patients are mostly 65 years or older, we repeated the aforementioned analyses but restricted ACS NSQIP population to those patients older than 64 years as a sensitivity check. All analyses were performed using SAS statistical software (release 9.3; SAS Institute Inc, Cary, NC). Statistical significance was set at the 0.05 level. The study was reviewed by the Northwestern University institutional review board.
RESULTS

Hospital VTE Event Rates
From the 208 hospitals that had data for both VTE imaging use rates and VTE event rates, 131,512 patients from the ACS NSQIP database were used to calculate the hospital risk-adjusted VTE event rates. The majority of these patients were younger than 65 years (63.4%), were white (77.4%), had independent functional status (93.6%), and had American Society of Anesthesiologists class II or III status (89.0%) ( Table 1 ). The overall 30-day VTE rate in the study cohort was 1.6% (DVT rate 1.1%, PE rate 0.6%). When limited to the inpatient-only period, the VTE rate was 1.0% (DVT rate 0.8%, PE rate 0.3%).
Hospital VTE Imaging Use Rates
Hospitals had a mean of 5.27 (SD = 1.54) VTE imaging studies per 100 cases in quartile 1, 8.19 (SD = 0.76) in quartile 2, 10.99 (SD = 0.82) in quartile 3, and 15.94 (SD = 3.23) in quartile 4 (P < 0.001; Table 2 ). Hospital DVT imaging rates were significantly correlated with hospital PE imaging rates (Spearman ρ = 52.1%; P < 0.001; Fig. 1 ).
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Hospital Characteristics
Of the 208 hospitals, 94 (45.2%) had more than 500 beds, 107 (51.4%) were members of the Council of Teaching Hospitals and Health Systems, and 161 (78.2%) had residency programs approved by the Accreditation Council for Graduate Medical Education ( Table  3 ). The majority of these hospitals were accredited by The Joint Commission (n = 189; 91.8%) or had a cancer program accredited by the ACS Commission on Cancer (n = 170; 82.5%), but only a minority provided burn services (n = 44; 21.4%).
Evaluation of Surveillance Bias
For VTE events captured at 30 days, the mean risk-adjusted VTE event rate for hospitals in VTE imaging use rate is as follows: quartile 1, 1.13% (SD = 0.70); quartile 2, 1.46% (SD = 0.77); quartile 3, 1.49% (SD = 0.75); and quartile 4, 1.92% (SD = 1.45) (P = 0.001 for trend and P < 0.05 pairwise compared with the fourth quartile; Table 2 ). For VTE events captured during the inpatient-only period, the mean hospital risk-adjusted VTE event rate for hospitals is as follows: quartile 1, 0.67% (SD = 0.52); quartile 2, 0.99% (SD = 0.95); quartile 3, 1.02% (SD = 0.2); and quartile 4, 1.33% (SD = 1.53) (P = 0.002 for trend and P < 0.050 pairwise compared with the fourth quartile; Fig. 2 ). The same trends were found when examining DVT and PE events separately. The mean hospital risk-adjusted DVT event rates increased from 0.48% (SD = 0.46) in quartile 1 to 1.00% (SD = 0.66%) in quartile 4 for DVT events captured during the inpatient-only period and from 0.81% (SD = 0.64) in quartile 1 to 1.35% (SD = 0.76) in quartile 4 for DVT events captured at 30 days. The mean hospital risk-adjusted PE event rates increased from 0.21% (SD = 0.23) in quartile 1 to 0.45% (SD = 0.53) in quartile 4 for PE events captured during the inpatient-only period and from 0.41% (SD = 0.35) in quartile 1 to 0.70% (SD = 0.62) in quartile 4 for PE events captured at 30 days (see Supplemental Digital Content Table 3 , available at http://links.lww.com/SLA/A596).
When examining the influence of hospital VTE imaging use rate in comparison with other hospital characteristics (eg, bed size, teaching status, and the number of other structural quality characteristics) on risk-adjusted VTE event rates at 30 days after the surgery, only the fourth quartile of VTE imaging use rate was significantly associated with risk-adjusted VTE event rates (P < 0.001), whereas the second and third quartiles had nonsignificant trends for the association with risk-adjusted VTE event rates (P = 0.055 and P = 0.053, respectively). For the inpatient-only period, the third and fourth quartiles of VTE imaging use rate were significantly associated with risk-adjusted VTE events (P = 0.046 and P = 0.001, respectively). None of the other hospital characteristics had a significant association with riskadjusted VTE event rates (Table 4 ). Similar findings were seen when examining DVT and PE events separately (see Supplemental Digital  Content Table 4 , available at http://links.lww.com/SLA/A596).
Results from sensitivity analyses restricting the ACS NSQIP population to patients 65 years or older were similar to the aforementioned findings.
DISCUSSION
VTE remains one of the leading causes of morbidity and mortality for hospitalized patients, 1-3 and it has been used in several public reporting and value-based purchasing initiatives. 8 However, using VTE event rates to judge a hospital's quality and ability to prevent VTE may be flawed. In our study using rigorously collected and validated clinical data for VTE event ascertainment and risk adjustment, we found that hospitals that perform more VTE imaging studies (eg, VTE imaging use rate quartile 4) had higher rates of observed and risk-adjusted VTE event rates than those hospitals that perform fewer studies (quartile 1). These trends were statistically significant for VTE events captured at 30 days and during the inpatient-only period. Moreover, hospitals that had higher rates of DVT imaging studies had higher rates of PE imaging studies. VTE imaging rate was the most important predictor of hospital VTE event rate. We were able to support the findings from previous studies that the presence of surveillance bias exists for the VTE outcome measure. In several studies focused on trauma patients, using data from single institution and the National Trauma Data Bank, trauma centers that performed more venous duplex studies had a higher rate of DVT events, 12, 14, 15 but this was mostly due to routine venous duplex screening practices in asymptomatic trauma patients. 13 In our study, we were able to broaden the study cohort to extend beyond the trauma patients to populations in which routine screening is generally not performed. We included 131,512 patients with various physical status and comorbidities who underwent 11 types of operations among 208 ACS NSQIP hospitals nationwide. We continue to observe that hospitals that were frequent users of VTE imaging studies had higher rates of observed and risk-adjusted VTE events.
In a recent study of nearly 1 million Medicare beneficiaries from more than 2800 hospitals, we demonstrated a surveillance bias in the measurement of VTE event rates. 10 However, the study has been criticized because we used administrative billing data for VTE event ascertainment (ie, less accurate than clinical data), 17, 18 risk adjustment of VTE event rates using PSI-12 methodology (ie, potentially inaccurate coding and insufficient risk adjustment), [32] [33] [34] and restriction to only inpatient data and patients older than 65 years. By using more robust clinically abstracted data from ACS NSQIP, we had more accurate ascertainment of VTE events and were able to better adjust for patient risk factors. Some might argue that certain hospitals have higher risk patients and therefore have higher VTE event rates. We were able to better account for this by using the standard ACS NSQIP risk adjustment using more than 30 variables. 22 Moreover, because ACS NSQIP collects 30-day data, we were also able to extend our study beyond the inpatient period and capture VTE events postdischarge. The results of the present study are not only consistent with the previous study, which found that hospitals that were frequent users of VTE imaging studies had higher rates of inpatient VTE, but also our current study finds that the rate of 30-day VTE is associated with hospital volume of VTE imaging. In addition, we sought to assess hospital characteristics associated with VTE event rates. Prior studies have offered conflicting findings regarding the effect of hospital volume. Whereas Altom et al 35 found that Veterans Administration hospital surgical volume accounted for less than 1% of the variation in hospital VTE rates, Vartak et al 36 demonstrated that larger hospitals had higher VTE rates. Other studies had shown that VTE rates were higher at teaching hospitals. 36, 37 In our study, we examined a large number of private hospitals of different sizes and teaching status. We found that these hospital factors, along with structure quality characteristics such as Joint Commission or ACS Commission on Cancer accreditation, level I trauma center certification, and burn or transplant services, were not significant in predicting hospital event rates when we had taken into account hospital VTE imaging use rates. In other words, no matter the hospital characteristics, only VTE imaging use rate was significant in predicting hospital VTE event rate. Moreover, hospitals that were frequent users of DVT imaging study were frequent users of PE imaging studies.
This study should be interpreted considering some limitations. First, there may be a sampling bias because we only examined ACS NSQIP hospitals. However, this allowed us to examine the VTE surveillance bias issue using robust clinical data and overcome the limitation of previous studies. Second, inpatient VTE imaging use rates from our study were limited to Medicare patients but VTE event rates were calculated from all patients in ACS NSQIP undergoing the same 11 procedures regardless of age or insurance status. Nevertheless, we would expect that hospitals order VTE imaging studies similarly regardless of insurance status and therefore hospitals would remain in the same VTE imaging use rate quartiles if non-Medicare patients could be included. In addition, we had conducted sensitivity analyses by restricting ACS NSQIP population to patients 65 years or older and found similar results. Third, there may be differences in the procedure mix in the Medicare and ACS NSQIP subpopulations within hospitals. The implication is that Medicare surgical populations may have different proportions of procedures that may entail higher VTE risk or VTE imaging utilization in which case the aggregate Medicare imaging utilization rate may be an inaccurate proxy for surveillance in other populations. Unfortunately, we were unable to assess and/or adjust for potential differences in procedure mix across the Medicare and ACS NSQIP subpopulations within a hospital, given that the exact sampling schedule for each ACS NSQIP hospital is unknown in the available data. However, this was the only way to conduct this study, given available national data: Medicare claims data currently represent the only way to obtain detailed data on VTE imaging use rates for most hospitals in the United States, and the ACS NSQIP data offer the best and largest sample of clinical data for accurate VTE ascertainment and risk adjustment. Fourth, there may be other confounding patient or hospital characteristics that were not accounted for in the VTE event rate risk adjustment. These unmeasured confounders could further diminish the VTE event rate differences among the quartiles of VTE image use rate, but using the clinical ACS NSQIP data gives us the best risk adjustment currently possible. In addition, there might be hospitals that provide lower value care at either spectrum of VTE imaging use. Some low imaging use hospitals might be underdetecting VTE because they did not image for VTE, whereas some high imaging use hospitals might be overtreating patients with clinically insignificant VTE that would otherwise not be found and are inconsequential. Both scenarios are potentially associated with higher morbidity, mortality, and cost. It is possible that due to the discovery of inconsequential VTE, hospitals with lower rates of VTE imaging (and detection) have no less VTE-related morbidity and mortality, and also have lower costs of care, thus potentially providing higher value care. We were unable to discern clinically relevant from irrelevant clots using our data sources. Further research is needed to better understand these issues.
Finally, there may be many other hospital accreditations or quality initiatives that reflect a hospital's commitment to providing higher quality, specialized care. We a priori selected a subset of established hospital characteristics to examine this phenomenon of VTE imaging use rates related to VTE event rates.
CONCLUSIONS
By using clinical data to examine accurate VTE outcomes and detailed patient-level risk adjustments, we were able to verify the findings and address criticisms of previous studies. We found that a surveillance bias affects VTE measurement. Hospitals may be unfairly deemed a poor performer for the outcome VTE measure if they have increased vigilance for VTE by performing more VTE imaging studies that result in higher VTE event rates. VTE rates may not accurately reflect a hospital's ability to prevent VTE. Further research on incorporation of appropriate VTE prophylaxis and image use in addition to VTE rates is necessary to improve the current VTE performance measures.
DISCUSSANTS S. Finlayson (Salt Lake City, UT):
That's an excellent use of both administrative and clinical data, and some expert analytic modeling. This is really important work assessing the appropriateness of VTE as a quality measure.
I have a couple of comments. The first is, what your study shows is a statistically convincing association between imaging and VTE incidence, but the conclusion that more imaging is driving discovery of VTE is, of course, an assumption. By the same logic, you could assume that high VTE incidence was resulting in greater rates of imaging, which, of course, is also plausible.
These, of course, are not mutually exclusive conclusions. Both mechanisms could in fact be operative; that is, more imaging results in greater rates of discovery of VTE and more VTE is also leading to more imaging. But in any event, ascribing the entire effect to one conclusion overstates the case for that chosen conclusion.
Your work showing better compliance with VTE-related process measures being associated with higher VTE rates certainly argues for your interpretation, but this study is really agnostic with respect to cause and effect.
The second comment: Let's assume that the imaging is driving VTE discovery. Let's also assume that clinically significant VTE eventually almost always comes to light. If this is true, then higher rates of imaging are probably driving the discovery of a lot of clinically insignificant VTEs. So the question remains, is aggressive VTE imaging actually a good thing? Could greater discovery of VTE be leading to higher treatment expense and treatment morbidity for clinically insignificant VTE. And in this day and age, does that represent low-value care?
So the question is, have you or could you look at outcomes of VTE across a spectrum of hospitals? It could be that greater vigilance or more imaging results in earlier diagnosis and better rescue from VTE. Now, as you know, the NSQIP time stamps complications. So could you look at the downstream secondary complications after VTE; in other words, mortality, cardiovascular collapse, etc, to determine whether higher rates of VTE discovery are leading to lower total VTE-related morbidity and mortality? Or stated another way, is a higher level of vigilance resulting in better rescue from VTE?
Response From K. Bilimoria:
With respect to the first question, I completely agree with you that we haven't definitively demonstrated causality here. We are trying to put forth this hypothesis, and the other evidence that we have around this question, such as the VTE surgical care improvement project (SCIP) prophylaxis measure performance and inverse correlation with other hospital quality scores, as we showed in our prior study, all support our hypothesis. This all suggests that there may be some effect of imaging being the driver of why some hospitals have VTE rates that are high. Certainly, in that group that has high VTE imaging rates, there is misclassification due to hospitals that look a lot with VTE imaging studies. However, there are certainly hospitals in that group that have problems with VTE. So that has been our next step in this work: trying to determine the misclassification in that group so that we can actually identify the poor-performing hospitals and separate them from hospitals that have "poor performance" due to a high imaging rate.
Hospitals certainly are probably picking up a lot of subclinical VTEs by ordering a lot of imaging studies. Thus, there is certainly some component of overuse. But it's hard to tell people when to image and when not to image. As a disclosure, our hospital had a high VTE rate. When we looked at this, we had one of the highest imaging rates in the country. So many at the hospital said, "Well, this is overuse." Certainly, we were finding a lot of subclinical VTEs. But we have had a hard time telling people when to image and when not to image. If they see a swollen leg, should they presume that it's due to fluid overload? You could talk about bilateral swollen legs and being up 20 lb in weight postoperative, but, frequently, people are unwilling to miss a VTE and would still get a venous duplex ultrasonogram on such a patient. At this point, I'm still unwilling to miss a VTE. I would rather treat only if clinically significant, but acknowledging that there are certainly very serious ramifications of anticoagulating patients with subclinical VTE.
DISCUSSANTS H. Polk (Louisville, KY):
I want to congratulate the authors for tackling a minefield that is, I think, one of the most dangerous fields in which to do clinical research in today. There are several points I'd like to bring up.
First of all, I want to ask if you-and I presume you don'thave information about the use of mechanical devices in addition to pharmaceutical devices? That's generally missing from most articles about this.
Furthermore, the corruption of workers in this field by the drug companies has been total. For example, most of you will remember the supplement to Chest put out in 2004. Many of them were distributed to clinical practicing surgeons. More than two thirds of their authors had to admit disqualifying conflicts of interest as they recommended more and more pharmacologic prophylaxis for DVT.
You have already put a lot of emphasis on what I think is the whole issue, and that is to what degree is an abnormal Doppler finding clinically significant disease and whether you're finding something to prove your effect.
Our work, which was published in Annals of Surgery in 2011, put substantial interest in looking at what happened in 2004 and what happened in 2008. What we found out was that there had been a steady increase in the use of pharmacologic prophylaxis with blood thinners from 2004 to 2008 by virtually all surgical specialties, as the drug companies wanted. What was interesting in all of that is virtually none of those specialties had a reduction in the frequency of VTE events. They gave more, they did better, but it had no impact.
Perhaps, the authors' example is correct here exactly. I want to say again that for elective surgery, VTE events are very rare killers. Most of those numbers are way under 1%. VTE is not, in my opinion, and for the reasons I have already said, cannot be a very valid quality indicator. There are just too many things in the field that confuse it in every sense of the word.
A senior surgeon always wants to end up with reporting a single case. In the midst of those hundreds of thousands of patients we looked at from UHC, there were 16,000 female patients who had hysterectomies in 2008 whose judgment by their gynecologists was that they needed no prophylaxis. The 16,000 female patients had one PE. It was nonfatal!
Response From K. Bilimoria:
We don't have any information here on either mechanical or chemoprophylaxis that patients received in these data sets. The best we can do is to use the hospital-level SCIP VTE prophylaxis adherence measure rate as a proxy for that. That's really the best we can provide. I appreciate your other comments.
DISCUSSANTS C. Baker (Roanoke, VA):
Dr Cole, a couple of years ago, presented data at this association's meeting looking at process measures compared with outcome measures and showing that process measures such as SCIP aren't really valid. We have found the same thing in our data.
The one real question is, looking at the hospitals based on imaging rates, could you correlate how they looked with respect to observed to expected ratios that are published by NSQIP?
DISCUSSANTS D. Flum (Seattle, WA):
As Dr Polk mentioned, you are swimming in some sharkinfested water. There's a lot of interest in this area. I have one specific question.
Clearly, the issue here is whether or not this is surveillance by us. Your abstract is definitely taking a side on that. I would caution you to broaden the perspective. As the first discussant mentioned, it could be either scenario.
But I wonder, if you looked at sudden death instead of VTE, whether or not you could get out of this dilemma altogether, because those sudden death events, if your theory is right, you would expect to see more of those, or less of those perhaps, in the hospitals of interest. Have you looked at sudden death and can you look at sudden death?
Response From K. Bilimoria:
Death from PE is actually fairly rare. We tried to look at it, and it's very hard to get enough events even with the national full data set. Moreover, you still don't know whether it was a cardiac event or whether it was a PE or what really caused the death. We don't have great cause-of-death information on a lot of these patients. So I think that makes it challenging to study the outcome that everybody is probably most interested in, death from PE. I take your first point very seriously, in that we have only demonstrated this association with imaging and VTE rates. But I think it's been observed clinically by lots of clinicians. It seems to fit with our intuition as clinicians. We have seen lots of hospitals with screening protocols that, of course, would have high VTE event rates if they imaged 100% of their patients-they would find many more subclinical VTEs. We also have consistent findings when looking at the SCIP data: the higher VTE event rate hospitals had the highest VTE SCIP prophylaxis measure adherence. Moreover, our prior work showed that hospitals with higher composite quality scores had worse performance on the VTE measure but better performance on the SCIP VTE prophylaxis measure. This all goes to the argument that higher VTE imaging rates and the resulting higher VTE rates may reflect better quality care to some degree. Based on these findings and our prior study, NSQIP has removed VTE from many of the composite complication models. Last week, University Health System Consortium also announced that they are removing it from their composite measure used for identifying their top hospitals.
